Noevir Holdings Co., Ltd. (TYO:4928)

Japan · Delayed Price · Currency is JPY

4,220.00

-5.00 (-0.12%)

Jun 19, 2026, 9:40 AM JST

-0.59% (1Y)

Market Cap	144.31B +0.4%
Revenue (ttm)	63.30B -1.5%
Net Income	8.11B +1.2%
EPS	237.35 +1.2%
Shares Out	34.16M
PE Ratio	17.80
Forward PE	18.04
Dividend	230.00 (5.47%)
Ex-Dividend Date	Sep 29, 2026

Volume	7,400
Open	4,225.00
Previous Close	4,225.00
Day's Range	4,210.00 - 4,230.00
52-Week Range	4,190.00 - 4,795.00
Beta	0.12
Analysts	Hold
Price Target	4,370.00 (+3.56%)
Earnings Date	Aug 3, 2026

About Noevir Holdings

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and... [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 1964

Employees 1,354

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4928

Full Company Profile

Financial Performance

In fiscal year 2025, Noevir Holdings's revenue was 64.72 billion, an increase of 1.41% compared to the previous year's 63.82 billion. Earnings were 8.03 billion, an increase of 0.75%.

Financial Statements